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There are reports of children COVID-19 or COVID-19 like symptoms with hyperinflammatory multi-
system syndrome, ARDS, gastrointestinal and atypical Kawasaki disease presenting to PICU worldwide
temporally associated with COVID-19, for which there are important nutrition support considerations. As
a result, the European Society of Pediatric and Neonatal Intensive Care e Metabolism, Endocrine and
Nutrition group (ESPNIC-MEN) and paediatric nutritionists working in PICUs are being consulted
regarding nutrition management of critically ill children with COVID-19 or COVID-19 like symptoms.
Therefore, the aim of this short report is to provide a summary of nutrition support recommendations for
critically ill children with COVID-19. They are based on the ESPNIC-MEN section recommendations
published in January 2020 and surviving sepsis recommendations from February 2020.
© 2020 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
The novel severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) was first identified in Wuhan, China, December 2019
[2]. TheWorld Health Organization (WHO) declared the outbreak of
SARS-CoV-2 disease (COVID-19) a pandemic in March 2020, and to
date there have been over 3.5 million cases, 250,000 deaths
affecting 215 countries around the world [3]. Although children
remain largely unaffected and only represent 2% of cases [4], a
cumulative pediatric infection proportion model of 50% estimates
there would be 37 million children infected with SARS-CoV-2, of
which almost 100,000 would require hospitalization for severe
pneumonia and nearly 11,000 would require admission totensive Care, Department of
ntre, Sophia Children’s Hos-
.T. Verbruggen).
r Ltd. This is an open access article
lla, L.N. Tume et al., Considera
ndrome temporally associaPaediatric Intensive Care unit (PICU) [5]. It is anticipated this cur-
rent pandemic will last for months, if not years with significant
health implications for children with regards to short and longer
term nutritional support and recovery.
There are reports of children with COVID-19 or COVID-19 like
symptomswith hyper inflammatorymulti system syndrome, ARDS,
gastrointestinal and atypical Kawasaki disease presenting to PICU
worldwide paediatric, for which there are important nutrition
support considerations. As a result, the European Society of Pedi-
atric and Neonatal Intensive Care e Metabolism, Endocrine and
Nutrition group (ESPNIC-MEN) and paediatric nutritionists work-
ing in PICUs are being consulted regarding nutrition management
of critically ill children with COVID-19 or COVID-19 like symptoms.
Therefore, the aim of this editorial is to provide an adaptation of
nutrition support recommendations for the overall population of
critically ill children, to provide further refined recommendations
for critically ill children presenting with COVID-19 or paediatric
hyper-inflammatory syndrome temporally associated with COVID-under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
tions for nutrition support in critically ill childrenwith COVID-19 and
ted with COVID-19, Clinical Nutrition, https://doi.org/10.1016/
L.V. Marino, F.V. Valla, L.N. Tume et al. Clinical Nutrition xxx (xxxx) xxx19. They are based on the ESPNIC-MEN section recommendations
published in January 2020 [6] and Surviving Sepsis Campaign rec-
ommendations from February 2020 [7]. These recommendations
cover the acute, stable and rehabilitation phases (Tables 1 and 2).
2. Clinical presentation of critically ill children with severe
SARS-CoV-2 disease
In adults, the severity of COVID-19 disease is postulated to arise
from renin-angiotensin system (RAS) and the angiotensin-
converting enzyme (ACE)2 receptor on cells which the virus uses
as a mode of cell entry. Individuals with high ACE2 levels e.g. dia-
betes or low levels e.g. hypertension may have a dysregulated
response leading to pulmonary inflammation and acute respiratory
distress syndrome (ARDS) [8,9]. Although ACE2 receptors are pre-
dominantly found in the respiratory mucosa, they have been found
to be expressed in the gastrointestinal tract, which may facilitate
viral entry into the epithelial cells within the gastrointestinal tract
[10,11].
ARDS induced hypoxia, inotrope resistant shock, dehydration
from fever, vomiting and diarrhoea, elevated liver enzymes, coag-
ulation dysfunction, rhabdomyolysis including other manifesta-
tions suggests injuries to vital organs [12,13]. ARDS remains a rare
clinical feature of COVID19 in paediatrics. However, very recently
clinicians have been reporting a rise in the number of children of all
ages presenting with a paediatric multisystem inflammatory syn-
drome associated with COVID-19, eventually leading to hyper-
inflammatory shock and associated with myocarditis; common
features of this syndrome are toxic shock syndrome, atypical Ka-
wasaki Disease, macrophage activation syndrome and bacterial
sepsis with cardiac inflammation; serum blood measures are
similar to severe COVID-19, although many have negative SARS-
CoV-2 real-time reverse transcription (rRT-PCR) tests while some
present with positive SARS CoV2 serology [13e15].
In children atypical Kawasaki disease symptoms include
vasculitis changes in peripheral and visceral arteries including ce-
rebrovascular, renal and gastrointestinal systems [13,15]. Gastro-
intestinal tract involvement is reported in approximately 20e35%
of atypical Kawasaki disease cases with varying clinical manifes-
tations such as vomiting, diarrhoea, abdominal pain, abdominal
distension, jaundice, paralytic ileus, hepatomegaly, and ultrasoundTable 1
Summary of nutrition requirements during acute, stable and recovery phase of paediatri
Acute phase
Enteral nutrition (Preferred route)
Energy It is recommended to commence early ente
admission unless contraindicated (e.g. ina
perfusion and rising lactate)
Protein (g/kg/day) 1e2
Parenteral nutrition




28 d-10 kg 2-4 (2.9e5.8)
11e30 kg 1.5e2.5 (1.4e2.2)
31e45 kg 1e1.5 (1.4e2.2)
>45 kg 0.5e1 (0.7e1.4)
Protein (g/kg/day) 0
2
findings of hydrops of the gallbladder, pancreatitis, gastrointestinal
obstruction/pseudo-obstruction [13,16].
3. Considerations for nutrition support in COVID-19 and
paediatric inflammatory multisystem syndrome temporally
associated with COVID-19
Gastrointestinal symptoms reported amongst children and
adults in Wuhan in the later stages of the epidemic with COVID-19
were thought to arise from infected epithelial cells [10]. Although
less than 10% of children with COVID-19 develop diarrhea or
vomiting, reports of prolonged reverse transcription-polymerase
chain reaction (RT-PCR) positivity in the stool has raised the
concern of faeco-oral transmission [11]. The newer gastrointestinal
and atypical Kawasaki disease presentation may mean that feeding
is more delayed than usual in some children, especially if this is
indicative of a novel COVID-19 direct intraluminal viral process
(PCRs negative in stool to date).
The cornerstones of nutrition recommendations for critically ill
children remain early enteral feeding within 24 h of admission,
energy requirements not to exceed resting energy expenditure
during the acute phase and parenteral nutrition to be withheld
during the first 7 days of admission (Fig. 1, Table 1). For critically ill
children with severe COVID-19 and COVID-19 like symptoms there
are a number of different nutritional considerations including; 1)
severe gastrointestinal or cardiac manifestations and inotrope
resistance shockmaymean usual early gastric enteral feeding is not
be possible, in these instances it may be possible to consider
providing enteral feeds via a post-pyloric tube, 2) the placement of
naso-enteric tube is considered aerosol producing and as such
appropriate personal protective equipment should be worn, 3)
childrenwho are nursed prone or in a medically induced comamay
tolerated post-pyloric feeds better, 4) measurement of GRV is not
recommended unless there is repeated vomiting and no possibility
to increase gastric enteral feeding (measured additional care
should be taken using personal protective equipment (PPE) as
SARS-COV 2 virus has been found in the gastrointestinal lumen, 5)
there is no evidence to support supra-physiological doses of
micronutrient supplementation, including zinc during the acute
phase [17], and 6) as children may have undergone a prolonged
admission to PICU, nutrition support may be required well into thec critical illness [1,18e21].
Stable phase Recovery phase
ral nutrition (EN) within 24 h of
dequate signs of systemic
EN may need to be
continued for longer
into the recovery phase





5-10 (7.2e14) 5-10 (7.2e14)
4-6 (5.8e8.6) 6-10 (8.6e14)
2-4 (2.8e5.8) 3-6 (4.3e8.6)
1.5e3 (2.2e4.3) 3-4 (4.3e5.8)
1-2 (1.4e2.9) 2-3 (2.9e4.3)
1e2 2e3
Table 2
Considerations for nutrition support in critically ill children with COVID-19 and Paediatric inflammatory multisystem syndrome temporal systems (PMS-TS) [7,19].
Question Recommendation for critically ill children [7] COVID-19 adapted recommendations
In critically ill children, when should enteral
nutrition (EN) be commenced and how
should it be increased?
 It is recommended to commence early EN within
24 h of admission unless contraindicated (e.g.
inadequate signs of systemic perfusion and rising
lactate)
 It is recommended to increase EN in a stepwise
fashion until goal for delivery is achieved using
a feeding protocol or guideline
 For children with the newer gastrointestinal and atypical
Kawasaki disease presentation may mean that feeding is
more delayed than usual in some children, especially if this
indicative of a novel COVID-19 direct intraluminal viral pro-
cess, (PCRs negative in stool to date)
 Corticosteroid and high dose aspirin may increase the risk of
gastritis and children may benefit from prophylactic
treatment to prevent upper gastrointestinal bleeding [22]
 Some of these children are reported to have body mass
index > 91st centile; energy requirements should be
calculated on using ideal body weight [23]
In critically ill children on hemodynamic
support (vasoactive medications,
extracorporeal life support ECLS) does
enteral feeding compared to no enteral
feeding affect outcomes?
 Early EN is recommended in term neonates/
children who are stable on ECLS
 Early EN is recommended in term neonates/
children who are stable on pharmaceutical
hemodynamic support
 However, in children who continue to require fluid
resuscitation or escalating doses of vasoactive agents (e.g.
inadequate signs of systemic perfusion and rising lactate),
with evidence of severe gastrointestinal dysfunction and
atypical Kawasaki disease, EN may be withheld for up to 7
days [7,19]
What are critically ill children requirements?  In the acute phase, energy intake provided to
critically ill children should not exceed resting
energy expenditure
 After the acute phase, energy intake provided to
critically ill children should account for energy
debt, physical activity, rehabilitation and growth
 Measuring resting energy expenditure using a
validated indirect calorimeter should be
considered to guide nutritional support or
Schofield equations [24] are recommended to
estimate resting energy expenditure
 For critically ill infants and children on enteral
nutrition a minimum enteral protein intake of
1.5 g/kg/d can be considered to avoid negative
protein balance
 Due to the gastrointestinal and atypical Kawasaki disease EN
support may need to be continued for longer into the
recovery phase until sufficient oral intake is consistently
achieved to support physical and nutritional rehabilitation
[18]
 An unknown is whether muscle mass loss may be more
pronounced in children with severe disease and energy,
protein deficits should be avoided
 The use of indirect calorimetry (IC) should be risk assessed
with benefits of using it against Schofield equations [24], as
limiting ventilator circuit disconnection will reduce virus
aerosolization
In critically ill children, do different feed
formulas (polymeric vs. semi-elemental feed,
standard vs. enriched formula) impact on
clinical outcomes?
 Polymeric feeds should be considered as the first
choice for EN in most critically ill children, unless
there are contraindications
 Protein and energy-dense formulations may be
considered to support achievement of nutritional
requirements in fluid-restricted critically ill
children
 Peptide-based formulations may be considered to
improve tolerance and progression of enteral
feeding in children for whom polymeric
formulations are poorly tolerated or contra-
indicated
 COVID 19 paediatric multisystem inflammatory syndrome
may be associated with severe gastrointestinal symptoms,
which may prevent early EN, or impact on its tolerance [16]
 In those where enteral feeding is possible a peptide based
feed may be better tolerated [25]
In critically ill children, does continuous feeding
compared to intermittent bolus gastric
feeding impact on outcomes?
 There is no evidence to suggest that either
continuous or intermittent/bolus feeds are
superior in delivering gastric feeds in critically ill
children
 In children with gastrointestinal symptoms
continuous feeds may be better tolerated with
or without a two- 4 h feed break within 24 h day
[25]
In critically ill children, does gastric feeding
compared to post-pyloric feeding impact on
clinical outcomes?
 Gastric feeding is as safe as post pyloric feeding in
the majority of critically ill children
 Gastric feeding is not inferior to post pyloric
feeding in the most critically ill children
 Gastric feeding is recommended over post-pyloric feeding in
children with severe sepsis/shock
 In an awake children e.g. not sedated/intubated, the
placement of naso-gastric tube is considered of naso-gastric
tube is considered to be an aerosol generating procedure
(AGP) and care should be taken to ensure health care pro-
fessional safety by wearing full personal protective equip-
ment [7,19]
 For children placed prone or those at increased risk of
vomiting or those with high gastric-residual volumes, post-
pyloric feeding may be superior
 In children where high levels of sedation including opioids or
muscle relaxants gastric emptying may be delayed
necessitating the use post pyloric feeding
 In an awake children, (e.g. not sedated/intubated) insertion of
a naso-jejunal tube may require more time and risk associ-
ated with this AGP
In critically ill children does routine Gastric
Residual Volume (GRV) to guide enteral
feeding impact on outcomes?
 Routine measurement of GRV in critically ill
children is not recommended
 Routine measurement of GRV is not recommended [7,19].
COVID-19 has been found in gastric and intestinal epithelial
cells [10] and as such additional care should be taken to ensure
(continued on next page)
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Table 2 (continued )
Question Recommendation for critically ill children [7] COVID-19 adapted recommendations
health care professional safety by wearing personal protective
equipment
 If GRV is measured, caution should be used avoiding contact
with the aspirate to avoid HCP contamination
 The use of closed draining systems are recommended if
feeding is not possible
In critically ill children, when should Parenteral
Nutrition (PN) be started?
 Withholding PN for up to one week can be
considered in critically ill term neonates and
children, independent of nutritional status, while
providing micronutrients [24]
 ESPGHAN/ESPEN recommendations on [18]
routine biochemistry should be completed prior
to commencement including triglyceride levels
(which may be high as a result of severe inflam-
matory response) and monitored throughout
PICU stay [19]
In critically ill children, does pharmaconutrition
(glutamine, lipids and/or micronutrients)
impact on clinical outcomes?
 There is insufficient evidence to recommend the
use of pharmaconutrition in critically ill children
 As this is such a novel infection, there may be negative
unintended consequences particularly if supra-physiological
doses of micronutrients are given [26]
 There is no evidence to support the use of supplemental
glutamine, which in severe sepsis may promote the release
of inflammatory mediators [27]
 In-vitro models of zinc supplementation have been shown to
have antiviral activity through inhibition of SARS-CoV RNA
polymerase, as well as down regulation of inflammatory
pathways. However, there is no currently no evidence to
support zinc supplementation, during the acute phase, in
children with COVID-19 [17]
L.V. Marino, F.V. Valla, L.N. Tume et al. Clinical Nutrition xxx (xxxx) xxxrecovery period to ensure adequate and appropriate nutrition re-
covery (Table 2).
3.1. Nutritional rehabilitation following PICU
The duration required for recovery is unknown so far. If chil-
dren have experienced severe disease physical and nutritionalFig. 1. Nutritional strategy in paed
4
rehabilitation may be required for a number of weeks [28]. During
recovery higher energy and protein intake may be required up to
twice the resting energy expenditure depending on age [18] until
nutritional deficits are replete. There is a paucity of information
relating to nutritional recovery in children following critical
illness. Close monitoring of nutritional status in addition to
nutrition support may be required post discharge as longer termiatric intensive care patients.
L.V. Marino, F.V. Valla, L.N. Tume et al. Clinical Nutrition xxx (xxxx) xxxfunctional outcomes have been associated with duration of me-
chanical ventilation, use of vasoactive medications and duration
of PICU stay [29].
In addition, the impact of paediatric critical illness on feeding
and feeding difficulties post-discharge remains unknown [30].
Adult survivors of critical care report significant changes to their
ability to eat, with reduced appetite, altered taste and food pref-
erences lasting up to 3months post ICU discharge, which is likely to
be an important consideration in children [31]. Adult recommen-
dations post-recovery include the use of enteral and oral nutrition
support [32,33]. As such EN support should continue after
discharge from PICU until children are able to eat able to consume
>75% of their nutrition requirements from food alone. Micro-
nutrient supplementation may also be required to support catch up
growth and muscle mass deposition, and serum levels should be
measured once the inflammatory response has resolved and CRP is
within normal range [26,34].
4. Limitations
Whilst the considerations for nutrition support in critically ill
children, are based on a peer review publication [6], the addition of
statements pertaining to the nutrition management of children
with COVID-19 and paediatric inflammatory multisystem syn-
drome temporally associated with COVID-19 are extrapolated from
other patient groups, as there is a paucity of published evidence
based nutrition therapy in critically ill children with COVID-19.
5. Conclusion
Early enteral feeding critically ill children with COVID-19 and
COVID-19 like symptoms should be considered. However, in those
with significant gastrointestinal issues or inotrope resistance shock
this may not be possible for several days. Clinicians should account
for gastrointestinal intolerance, taking factors influencing this
tolerance into account, and we recommend deciding early about
post-pyloric feeding and intuiting this if appropriate. In the acute
phase, energy intake provided to critically ill children should not
exceed resting energy expenditure and postponing parenteral
nutrition for 7 days may be considered. The placement of naso-
enteric tubes is considered AGP and as such appropriate personal
protective equipment should be worn and there is no evidence to
support supra-physiological doses of micronutrient supplementa-
tion, including zinc during the acute phase. As children may have
had a prolonged admission to PICU, nutrition support may be
required well into the recovery period to ensure adequate and
appropriate nutrition recovery.
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